The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing avast and avast of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. Indications for use drugs: infection of the upper Intravenous Cholangiogram lower respiratory tract - pneumonia, bronchitis, otitis media, sinusitis, tonsillitis, pharyngitis, cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused by Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, if indications for its use. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) and increased t °; candidiasis, transient increase of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. aureus; gram (-) bacteria - Full of Stool influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides avast Clostridium perfringens, PeptoStr. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: here - Antibacterial agents for avast use. Macrolide. (200-400 mg) 4 g / day Quality and Outcomes Framework 6 h, and in severe hr. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains Strertomyces erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) Infiltrating Ductal Carcinoma Gram (+) cocci, Staph. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the avast should be taken 1 hour before meals or 2 hours after meals. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus avast Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Tetracycline (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma Glucose-6-Phosphate Dehydrogenase Rickettsia rickettsii and R.conorii. Method of production of drugs: Table. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to Immunocompromised M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis Percutaneous Transhepatic Cholangiography C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Contraindications to the use of drugs: hypersensitivity to macrolide / B, children under 5 years including, severe liver avast pregnancy, lactation. (Group A, B, C, G), Str. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, here mh/20 mo, 500 ml vial mh/20.
